$21.49
-0.52-2.36%
Last update: Oct 30, 4:00 PM
Damora Therapeutics Inc (DMRA) Stock Price, Quote, News & History
DMRANASDAQ
U.S. stocks were mixed as the Dow gained 400 points. Winnebago jumped 7% on an EPS beat, while Super Micro and SpaceX rallied on strong outlooks.
You can purchase shares of Damora Therapeutics (NASDAQ:DMRA) through any online brokerage.
Other companies in Damora Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Damora Therapeutics has a consensus price target of $46.83.
The stock price for Damora Therapeutics (NASDAQ: DMRA) is $21.49 last updated October 30, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Damora Therapeutics.
Damora Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Damora Therapeutics.
Damora Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms,...
